Literature DB >> 34082699

Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.

Do Ngoc Anh1,2, Dao Nguyen Hung3, Tran Viet Tien3, Vu Nhat Dinh3, Vu Tung Son4, Nguyen Viet Luong5, Nguyen Thi Van6, Nguyen Thi Nhu Quynh7, Nguyen Van Tuan7, Le Quoc Tuan7,6, Nguyen Duy Bac8, Nguyen Khac Luc7,6, Le Tran Anh7,6, Do Minh Trung9.   

Abstract

BACKGROUND: Vaginal candidiasis is frequent in women of reproductive age. Accurate identification Candida provides helpful information for successful therapy and epidemiology study; however, there are very limited data from the Vietnam have been reported. This study was performed to determine the prevalence, species distribution of yeast causing vaginal discharge and antifungal susceptibility patterns of Candida albicans among symptomatic non-pregnant women of reproductive age.
METHODS: Vaginal discharge samples were collected from 462 women of reproductive age in Hanoi, Vietnam between Sep 2019 and Oct 2020. Vaginal swabs from these patients were examined by direct microscopic examination (10% KOH). CHROMagar™ Candida medium and Sabouraud dextrose agar supplemented with chloramphenicol (0.5 g/l) were used to isolate yeast, and species identification was performed using morphological tests and molecular tools (PCR and sequencing). Antifungal susceptibility testing was determined according to the Clinical and Laboratory Standards Institute guidelines (M27-A3 and M27-S4).
RESULTS: The prevalence of vaginal yeast colonization in non-pregnant women was 51.3% of 462 participants. Nine different yeast species were identified. Among these isolates, C. albicans (51.37%) was the most frequent, followed by C. parapsilosis (25.88%), C. glabrata (11.37%), C. tropicalis (4.31%), C. krusei (3.92%), C. africana (1.57%), Saccharomyces cerevisiae (0.78%), C. nivariensis (1 isolates, 0.39%), and C. lusitaniae (1 isolates, 0.39%), respectively. Among C. albicans, all 46 isolates were 100% susceptible to micafungin, caspofungin, and miconazole. The susceptibility rates to amphotericine B, 5-flucytosine, fluconazole, itraconazole and voriconazole were 95.65, 91.30, 91.30, 82.61 and 86.95%, respectively.
CONCLUSIONS: The prevalence of VVC among symptomatic non-pregnant women of reproductive age in Vietnam was higher than many parts of the world. The high frequency of non-albicans Candida species, which were often more resistant to antifungal agents, was a notable feature. Resistance rates of vaginal C. albicans isolates to antifungal agents was low. Our findings suggest that continued surveillance of changes in species distribution and susceptibility to antifungals should be routinely screened and treated.

Entities:  

Keywords:  Antifungal susceptibility; Prevalence; Reproductive age women; Vulvovaginal candidiasis

Year:  2021        PMID: 34082699     DOI: 10.1186/s12879-021-06192-7

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  42 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 2.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 3.  Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.

Authors:  Bruna Gonçalves; Carina Ferreira; Carlos Tiago Alves; Mariana Henriques; Joana Azeredo; Sónia Silva
Journal:  Crit Rev Microbiol       Date:  2015-12-21       Impact factor: 7.624

Review 4.  Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

Authors:  J D Sobel; S Faro; R W Force; B Foxman; W J Ledger; P R Nyirjesy; B D Reed; P R Summers
Journal:  Am J Obstet Gynecol       Date:  1998-02       Impact factor: 8.661

Review 5.  The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective.

Authors:  Macit Ilkit; Ahmet Baris Guzel
Journal:  Crit Rev Microbiol       Date:  2011-05-20       Impact factor: 7.624

6.  Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).

Authors:  Werner Mendling; J Brasch; O A Cornely; I Effendy; K Friese; G Ginter-Hanselmayer; H Hof; P Mayser; I Mylonas; M Ruhnke; M Schaller; E-R Weissenbacher
Journal:  Mycoses       Date:  2015-03       Impact factor: 4.377

Review 7.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Risk factors for vulvovaginal candidiasis: a case-control study among university students.

Authors:  A M Geiger; B Foxman
Journal:  Epidemiology       Date:  1996-03       Impact factor: 4.822

9.  Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species.

Authors:  Ali Rezaei-Matehkolaei; Shokoofe Shafiei; Ali Zarei-Mahmoudabadi
Journal:  Iran J Microbiol       Date:  2016-12

10.  Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.

Authors:  Nahed Ghaddar; Elie Anastasiadis; Rawad Halimeh; Ali Ghaddar; Rita Dhar; Wadha AlFouzan; Hoda Yusef; Mira El Chaar
Journal:  BMC Infect Dis       Date:  2020-01-13       Impact factor: 3.090

View more
  2 in total

1.  Novel Graphene Oxide/Quercetin and Graphene Oxide/Juglone Nanostructured Platforms as Effective Drug Delivery Systems with Biomedical Applications.

Authors:  Alexa-Maria Croitoru; Alina Moroșan; Bianca Tihăuan; Ovidiu Oprea; Ludmila Motelică; Roxana Trușcă; Adrian Ionuț Nicoară; Roxana-Cristina Popescu; Diana Savu; Dan Eduard Mihăiescu; Anton Ficai
Journal:  Nanomaterials (Basel)       Date:  2022-06-06       Impact factor: 5.719

2.  Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action.

Authors:  C I S Medeiros; M N A de Sousa; G G A Filho; F O R Freitas; D P L Uchoa; M S C Nobre; A L D Bezerra; L A D M M Rolim; A M B Morais; T B S S Nogueira; R B S S Nogueira; A A O Filho; E O Lima
Journal:  Braz J Med Biol Res       Date:  2022-08-15       Impact factor: 2.904

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.